Boothbay Fund Management’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-18,279
| Closed | -$109K | – | 1395 |
|
2025
Q1 | $109K | Hold |
18,279
| – | – | ﹤0.01% | 1056 |
|
2024
Q4 | $140K | Sell |
18,279
-10,189
| -36% | -$78.3K | ﹤0.01% | 1083 |
|
2024
Q3 | $291K | Buy |
28,468
+10,200
| +56% | +$104K | 0.01% | 1085 |
|
2024
Q2 | $271K | Sell |
18,268
-5,289
| -22% | -$78.5K | 0.01% | 1040 |
|
2024
Q1 | $321K | Sell |
23,557
-52,142
| -69% | -$711K | 0.01% | 1017 |
|
2023
Q4 | $829K | Buy |
75,699
+1,720
| +2% | +$18.8K | 0.02% | 665 |
|
2023
Q3 | $810K | Sell |
73,979
-1,521
| -2% | -$16.7K | 0.02% | 704 |
|
2023
Q2 | $1,000K | Buy |
75,500
+39,848
| +112% | +$528K | 0.02% | 685 |
|
2023
Q1 | $485K | Buy |
+35,652
| New | +$485K | 0.01% | 1062 |
|
2022
Q3 | – | Hold |
0
| – | – | – | 2113 |
|
2022
Q2 | – | Hold |
0
| – | – | – | 2130 |
|
2021
Q4 | – | Sell |
-9,888
| Closed | -$267K | – | 1842 |
|
2021
Q3 | $267K | Buy |
9,888
+778
| +9% | +$21K | 0.01% | 1167 |
|
2021
Q2 | $234K | Buy |
+9,110
| New | +$234K | 0.01% | 1262 |
|